COECSA, Journal, Ophthalmology
Prevalence of diabetic retinopathy and barriers to uptake of diabetic retinopathy screening at Embu Provincial General Hospital, Central Kenya



How to Cite

L, N. (2020). Prevalence of diabetic retinopathy and barriers to uptake of diabetic retinopathy screening at Embu Provincial General Hospital, Central Kenya. The Journal of Ophthalmology of Eastern, Central and Southern Africa, 16(1). Retrieved from


Background: The risk of Diabetic Retinopathy (DR) to sight can be greatly reduced by good blood glucose
and blood pressure control, effective screening and laser treatment. Diabetic retinopathy remains
asymptomatic in its early stages. Substantial barriers to screening and achieving regular eye examinations
for people with diabetes include the belief that ‘nothing is wrong with my eyes’, not being told of the need
for eye examinations and being too busy.
Objectives: To determine the prevalence of diabetic retinopathy, to describe the relationship between
diabetic retinopathy and the various risk factors and to identify the barriers to uptake of screening for
diabetic retinopathy in diabetic patients at Embu Provincial General Hospital, Central Kenya.
Study design: Cross sectional hospital based survey.
Subjects: Two hundred and fifty three type II Diabetics and type I diabetic patients aged twelve years and
above attending the diabetic clinic.
Results: The overall prevalence of Diabetic Retinopathy (DR) was 41%. Moderate Non Proliferative Diabetic
Retinopathy (NPDR) was the most prevalent grade of DR (20%). Vision threatening DR (Proliferative
Diabetic Retinopathy (PDR) and macular oedema) was found in 21 (8.3%) patients. Most of the patients
(74%) had hypertension. Duration of diabetes and systolic blood pressure had a significant association
with DR (p< 0.05). Fasting Blood Sugar (FBS), mode of treatment and age were not significant. Only 29%
of the patients had prior eye examination, with majority (84%) citing lack of awareness as the main
Conclusion: The prevalence of DR was high. Most of the patients had not had prior eye examination and
were not aware of the need or the importance of the eye examination.
Recommendation: Reinforce the existing screening programmes through education and promotion and
provision of laser treatment for blinding diabetic retinopathy.



World Health Organisation. The World Health Report

Available at:

King H, Aubert RE, Herman WH. Global burden of

diabetes, 1995–2025: prevalence, numerical estimates,

and projections. Diabetes Care 1998; 21: 1414–1431.

Diabetes action now. An initiative of World Health

Organization and international diabetic federation.

; Availableat:


National Society to Prevent Blindness. Visual Problems

in the US Data Analysis Definitions. Data Sources,

Detailed Data Tables, Analysis, Interpretation.

National Society to Prevent Blindness: New York,

; pp 1–46.

National Institutes of Health, National Institute

of Diabetes and Digestive and Kidney Diseases.

Diabetes in America, 2nd ed. National Institutes of

Health, National Institute of Diabetes and Digestive

and Kidney Diseases: Bethesda, MD, 1995.

Klein R, Klein BE, Moss SE, Davis MD, DeMets

D.L. The Wisconsin Epidemiologic Study of Diabetic

Retinopathy. II. Prevalence and risk of diabetic

East African Journal of Ophthalmology July 2012

retinopathy when age at diagnosis is less than 30

years. Arch Ophthalmol. 1984; 102: 520–526.

Aiello LP, Gardner TW, King GL, Blankenship G,

Cavallerano JD, Ferris FL et al. Diabetic retinopathy.

Diabetes Care. 1998; 21: 143–156.

Brown MM, Brown GC, Sharma S, Shah G. Utility

values and diabetic retinopathy. Am J Ophthalmol

; 128: 324–330.

U.K prospective Diabetes study (UKPDS) Group.

Tight blood pressure control and the risk of microvascular

complications in type II diabetics. UKPDS 38.

BMJ. 1998. 317: 703-713.

Will JC, German RR, Schurman E, Michael S, Kurth

DM, Deeb L. Patient adherence to guidelines for

diabetes eye care: Results from the diabetic eye

disease follow-up study. Am J Public Health. 1994;


Moss SE, Klein R, Klein BE. Factors associated with

having eye examinations in persons with diabetes.

Arch Fam Med. 1995; 4:529-534.

Aurangzeb S, Faheemullah S, Ziauddin A, Jamshed

A. Prevalence of diabetic retinopathy and influence

factors among newly diagnosed diabetics in rural and

urban areas of Pakistan: Data analysis from the Pakistan

National Blindness & Visual Impairment Survey

Pak J Med Sci. 2008 (Part-II); 24 (6): 774-779.

Kariuki M.M. et al. The prevalence, pattern and

associations of Diabetic Retinopathy among black

African diabetics attending the medical diabetes clinic

at KNH. M.Med Dissertation, U.O.N 1999.

Mutangana F, Kariuki M, Karimurio J. The magnitude

and pattern of diabetic retinopathy as seen at

three hospitals in Kigali, Rwanda. M.Med. Dissertation,

University of Nairobi. 2008.

Early Treatment Diabetic Retinopathy Study Research

Group. Classification of diabetic retinopathy

from fluorescein angiograms. ETDRS report number

Ophthalmology. 1991; 98(5 Suppl):807-822.

Fong DS, Aiello L, Gardner TW, King GL, Blankenship G,

Cavallerano. JD, et al for the American diabetic association.

Diabetic retinopathy. Diabetic Care. 2003;

: S99-102.

Lutale J, Thordarson H, Sanyiwa A, Mafwiri M,

Vetvik K, Krohn J. Diabetic retinopathy prevalence

and its association with microalbiminuria and other

risk factors in patients with type 1 and type 2 diabetes

in Dar er Salaam, Tanzania. East Afr J. Ophthalmol.

; 15 (1): 3-10.

Kibata G, Kollmann M, Adala H. The prevalence,

pattern and risk factors of diabetic retinopathy among

diabetic patients attending peripheral health institutions

in central Kenya. M.Med. Dissertation. University of

Nairobi. 2001.

Dowse G, Humphrey A, Collins V. et al. Prevalence

and risk factors for diabetic retinopathy in the

multiethinic population of Mauritius. Am J Epidemiol.

; 147: 448-457.

Agrawal R, Ranka M, Beniwal R, Gothwal S, Jain

G, Kochar D, Kothari R. Prevalence of diabetic

retinopathy in type 2 diabetes in relation to risk

factors: hospital based study. Int J. Diab. Dev.

Countries. 2003; 23: 16-19.

Haytham I.S, Mona PN, Nadine MT, Marie M, Sandrah

H, Jaafar E, et al, Prevalence and determinants of

retinopathy in a cohort of Lebanese type II diabetic

patients. Can J Ophthalmo. 2009; 44(3).308-313.

DCCT Research Group. The effect of intensive

treatment of diabetes on the development and

progression of long term complications in insulin

dependent diabetes mellitus. N Eng J Med. 1993;

; 977-986.

Sikivou TB, McCarty CA, Harper CA, Keeffe JE.

Barriers to access of eye examinations for people with

diabetes . Aust NZ J Ophthalmol. 1999; 27:281.

Miriam RC. Prevalence of diabetic retinopathy and

barriers to uptake of eye care services by diabetic

patients at the Social Security Institute Central

Hospital in Asunción, Paraguay. Community Eye

Health. 2007; 20(61): 10–11.

Bailey CC, Sparrow JM, Grey RH, Cheng H. The

National Diabetic Retinopathy Laser Treatment

Audit. III. Clinical outcomes. Eye. 1999; 13: 151–

| PubMed

Williams R, Airey M, Baxter H, Forrester J., Kennedy

Martin T., Girach A. Epidemiology of diabetic retinopathy

and macular oedema: a systematic review.

Eye. 2004; 18: 963–983.

Schoenfeld ER, Greene JM, Wu SY, Leske M.C. Patterns

of adherence to diabetes vision care guidelines: baseline

findings from the Diabetic Retinopathy Awareness

Program. Ophthalmology. 2001; 108: 563–571.


Download data is not yet available.